Hospira MitoXANTRONE Injection, USP (concentrate) 25 mg/12.5 mL vial

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

mitoxantrone (mitozantrone) hydrochloride, Quantity: 2.33 mg/mL (Equivalent: mitoxantrone, Qty 2 mg/mL)

Tersedia dari:

Hospira Australia Pty Ltd

INN (Nama Internasional):

mitoxantrone (mitozantrone) hydrochloride

Bentuk farmasi:

Injection

Komposisi:

Excipient Ingredients: water for injections; sodium acetate trihydrate; glacial acetic acid; sodium chloride; sodium metabisulfite

Rute administrasi :

Intravenous Infusion

Unit dalam paket:

1 x 12.5 mL vial

Kelas:

Medicine Listed (Export Only)

Jenis Resep:

Not scheduled. Not considered by committee

Indikasi Terapi:

Mitoxantrone in combination with corticosteroids is indicated as initial chemotherapy for the treatment of patients with pain related to advanced hormone-refractory prostate cancer. Mitoxantrone in combination with other approved drus(s) is indicated in the initial therapy of acute nonlymphocytic leukemia (ANLL) in adults. This category includes myelogenous, promyelocytic, monocytic, and erythroid acute leukemias.

Ringkasan produk:

Visual Identification: A clear, dark blue solution; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store between 15-25 degrees Celsius

Status otorisasi:

Licence status A

Tanggal Otorisasi:

2007-08-20